-+ 0.00%
-+ 0.00%
-+ 0.00%

Gulf Pharmaceutical Industries P.S.C's (ADX:JULPHAR) Earnings Are Weaker Than They Seem

Simply Wall St·11/20/2026 02:00:23
Listen to the news

Gulf Pharmaceutical Industries P.S.C.'s (ADX:JULPHAR) robust earnings report didn't manage to move the market for its stock. Our analysis suggests that this might be because shareholders have noticed some concerning underlying factors.

earnings-and-revenue-history
ADX:JULPHAR Earnings and Revenue History November 20th 2026

The Impact Of Unusual Items On Profit

To properly understand Gulf Pharmaceutical Industries P.S.C's profit results, we need to consider the د.إ14m gain attributed to unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Gulf Pharmaceutical Industries P.S.C's Profit Performance

Arguably, Gulf Pharmaceutical Industries P.S.C's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Gulf Pharmaceutical Industries P.S.C's true underlying earnings power is actually less than its statutory profit. The silver lining is that its EPS growth over the last year has been really wonderful, even if it's not a perfect measure. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. Obviously, we love to consider the historical data to inform our opinion of a company. But it can be really valuable to consider what other analysts are forecasting. At Simply Wall St, we have analyst estimates which you can view by clicking here.

Today we've zoomed in on a single data point to better understand the nature of Gulf Pharmaceutical Industries P.S.C's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.